Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 83

1.

A review of complement sources used in serum bactericidal assays for evaluating immune responses to meningococcal ACWY conjugate vaccines.

Findlow J, Balmer P, Borrow R.

Hum Vaccin Immunother. 2019 Mar 18:1-10. doi: 10.1080/21645515.2019.1593082. [Epub ahead of print]

PMID:
30883271
2.

[Year in review : geriatrics].

Stamm E, Acchini A, Da Costa A, Besse S, Christou F, Launay C, Balmer P, Humbert M, Nguyen S, Major K, Bosshard W, Büla C.

Rev Med Suisse. 2019 Jan 9;15(N° 632-633):50-52. Review. French.

PMID:
30629369
3.

Motivational interviewing increases autopsy rates.

Rosenberg I, Gierer B, Flury R, Battegay E, Balmer PE.

Swiss Med Wkly. 2018 Dec 2;148:w14679. doi: 10.4414/smw.2018.14679. eCollection 2018 Nov 19.

4.

Meningococcal disease in adolescents and young adults: a review of the rationale for prevention through vaccination.

Burman C, Serra L, Nuttens C, Presa J, Balmer P, York L.

Hum Vaccin Immunother. 2019;15(2):459-469. doi: 10.1080/21645515.2018.1528831. Epub 2018 Oct 29.

5.

Meningococcal Group A, C, W, and Y Tetanus Toxoid Conjugate Vaccine: A Review of Clinical Data in Adolescents.

Serra LC, York LJ, Balmer P, Webber C.

J Adolesc Health. 2018 Sep;63(3):269-279. doi: 10.1016/j.jadohealth.2018.05.012. Review.

PMID:
30236996
6.

Optimal use of meningococcal serogroup B vaccines: moving beyond outbreak control.

Balmer P, York LJ.

Ther Adv Vaccines Immunother. 2018 Jun 21;6(3):49-60. doi: 10.1177/2515135518781757. eCollection 2018 May. Review.

7.

FAM83G/Fam83g genetic variants affect canine and murine hair formation.

Balmer P, Fellay AK, Sayar BS, Hariton WVJ, Wiener DJ, Galichet A, Müller EJ, Roosje PJ.

Exp Dermatol. 2019 Apr;28(4):350-354. doi: 10.1111/exd.13729. Epub 2018 Aug 3.

PMID:
29963719
8.

From research to licensure and beyond: clinical development of MenB-FHbp, a broadly protective meningococcal B vaccine.

Perez JL, Absalon J, Beeslaar J, Balmer P, Jansen KU, Jones TR, Harris S, York LJ, Jiang Q, Radley D, Anderson AS, Crowther G, Eiden JJ.

Expert Rev Vaccines. 2018 Jun;17(6):461-477. doi: 10.1080/14760584.2018.1483726. Epub 2018 Jun 22. Review.

PMID:
29883226
9.

Clinical data supporting a 2-dose schedule of MenB-FHbp, a bivalent meningococcal serogroup B vaccine, in adolescents and young adults.

Beeslaar J, Absalon J, Balmer P, Srivastava A, Maansson R, York LJ, Perez JL.

Vaccine. 2018 Jun 27;36(28):4004-4013. doi: 10.1016/j.vaccine.2018.05.060. Epub 2018 Jun 1. Review.

PMID:
29861182
10.

Impact of meningococcal vaccination on carriage and disease transmission: A review of the literature.

Balmer P, Burman C, Serra L, York LJ.

Hum Vaccin Immunother. 2018 May 4;14(5):1118-1130. doi: 10.1080/21645515.2018.1454570. Epub 2018 May 9. Review.

11.

A Review of Meningococcal Disease and Vaccination Recommendations for Travelers.

Serra LC, York LJ, Gamil A, Balmer P, Webber C.

Infect Dis Ther. 2018 Jun;7(2):219-234. doi: 10.1007/s40121-018-0196-z. Epub 2018 Mar 17. Review.

12.

Vaccination strategies for the prevention of meningococcal disease.

Vuocolo S, Balmer P, Gruber WC, Jansen KU, Anderson AS, Perez JL, York LJ.

Hum Vaccin Immunother. 2018 May 4;14(5):1203-1215. doi: 10.1080/21645515.2018.1451287. Epub 2018 Apr 13. Review.

13.

A curated catalog of canine and equine keratin genes.

Balmer P, Bauer A, Pujar S, McGarvey KM, Welle M, Galichet A, Müller EJ, Pruitt KD, Leeb T, Jagannathan V.

PLoS One. 2017 Aug 28;12(8):e0180359. doi: 10.1371/journal.pone.0180359. eCollection 2017.

14.

A de novo germline mutation of DLX3 in a Brown Swiss calf with tricho-dento-osseus-like syndrome.

Hofstetter S, Welle M, Gorgas D, Balmer P, Roosje P, Mock T, Meylan M, Jagannathan V, Drögemüller C.

Vet Dermatol. 2017 Dec;28(6):616-e150. doi: 10.1111/vde.12462. Epub 2017 Jul 2.

PMID:
28670783
15.

Characteristics of a new meningococcal serogroup B vaccine, bivalent rLP2086 (MenB-FHbp; Trumenba®).

Gandhi A, Balmer P, York LJ.

Postgrad Med. 2016 Aug;128(6):548-56. doi: 10.1080/00325481.2016.1203238. Epub 2016 Jul 7. Review.

PMID:
27467048
16.

An Intronic MBTPS2 Variant Results in a Splicing Defect in Horses with Brindle Coat Texture.

Murgiano L, Waluk DP, Towers R, Wiedemar N, Dietrich J, Jagannathan V, Drögemüller M, Balmer P, Druet T, Galichet A, Penedo MC, Müller EJ, Roosje P, Welle MM, Leeb T.

G3 (Bethesda). 2016 Sep 8;6(9):2963-70. doi: 10.1534/g3.116.032433.

17.

History of Meningococcal Outbreaks in the United States: Implications for Vaccination and Disease Prevention.

Atkinson B, Gandhi A, Balmer P.

Pharmacotherapy. 2016 Aug;36(8):880-92. doi: 10.1002/phar.1790. Review.

PMID:
27332671
18.

PCVs in individuals at increased risk of pneumococcal disease: a literature review.

Fletcher MA, Balmer P, Bonnet E, Dartois N.

Expert Rev Vaccines. 2015 Jul;14(7):975-1030. doi: 10.1586/14760584.2015.1037743. Review.

PMID:
26083459
19.

A review of the impact of pneumococcal polysaccharide conjugate vaccine (7-valent) on pneumococcal meningitis.

Tin Tin Htar M, Madhava H, Balmer P, Christopoulou D, Menegas D, Bonnet E.

Adv Ther. 2013 Aug;30(8):748-62. doi: 10.1007/s12325-013-0051-2. Epub 2013 Sep 3. Review.

20.

The impact of 7-valent pneumococcal conjugate vaccine on invasive pneumococcal disease: a literature review.

Myint TT, Madhava H, Balmer P, Christopoulou D, Attal S, Menegas D, Sprenger R, Bonnet E.

Adv Ther. 2013 Feb;30(2):127-51. doi: 10.1007/s12325-013-0007-6. Epub 2013 Feb 7. Review.

PMID:
23397399
21.

Subclinical thyroid dysfunction and the risk of heart failure events: an individual participant data analysis from 6 prospective cohorts.

Gencer B, Collet TH, Virgini V, Bauer DC, Gussekloo J, Cappola AR, Nanchen D, den Elzen WP, Balmer P, Luben RN, Iacoviello M, Triggiani V, Cornuz J, Newman AB, Khaw KT, Jukema JW, Westendorp RG, Vittinghoff E, Aujesky D, Rodondi N; Thyroid Studies Collaboration.

Circulation. 2012 Aug 28;126(9):1040-9. Epub 2012 Jul 19.

22.

Subclinical hyperthyroidism and the risk of coronary heart disease and mortality.

Collet TH, Gussekloo J, Bauer DC, den Elzen WP, Cappola AR, Balmer P, Iervasi G, Åsvold BO, Sgarbi JA, Völzke H, Gencer B, Maciel RM, Molinaro S, Bremner A, Luben RN, Maisonneuve P, Cornuz J, Newman AB, Khaw KT, Westendorp RG, Franklyn JA, Vittinghoff E, Walsh JP, Rodondi N; Thyroid Studies Collaboration.

Arch Intern Med. 2012 May 28;172(10):799-809. doi: 10.1001/archinternmed.2012.402. Review.

23.

Performance indicators for wastewater treatment plants.

Balmér P, Hellström D.

Water Sci Technol. 2012;65(7):1304-10. doi: 10.2166/wst.2012.014.

PMID:
22437030
24.

Lifestyle intervention and cardiovascular risk reduction in the Illinois WISEWOMAN Program.

Khare MM, Carpenter RA, Huber R, Bates NJ, Cursio JF, Balmer PW, Nolen KN, Hudson H, Shippee SJ, Loo RK.

J Womens Health (Larchmt). 2012 Mar;21(3):294-301. doi: 10.1089/jwh.2011.2926. Epub 2011 Dec 2.

PMID:
22136298
25.

Immunoglobulin G deficiency in United kingdom children with invasive pneumococcal disease.

Stanford E, Ladhani S, Borrow R, Waight P, Slack M, George R, Balmer P, Miller E, Helbert M.

Pediatr Infect Dis J. 2011 Jun;30(6):462-5. doi: 10.1097/INF.0b013e3182191dfa.

PMID:
21487328
26.

The role of angiogenic factors in predicting clinical outcome in severe bacterial infection in Malawian children.

Mankhambo LA, Banda DL; IPD Study Group, Jeffers G, White SA, Balmer P, Nkhoma S, Phiri H, Molyneux EM, Hart CA, Molyneux ME, Heyderman RS, Carrol ED.

Crit Care. 2010;14(3):R91. doi: 10.1186/cc9025. Epub 2010 May 21.

28.

A lifestyle approach to reducing cardiovascular risk factors in underserved women: design and methods of the Illinois WISEWOMAN Program.

Khare MM, Huber R, Carpenter RA, Balmer PW, Bates NJ, Nolen KN, Hudson HK, Lattyak RM, Cursio JF, Loo RK, Farris RP, Will JC.

J Womens Health (Larchmt). 2009 Mar;18(3):409-19. doi: 10.1089/jwh.2008.0911.

PMID:
19281324
29.

Competitive inhibition flow analysis assay for the non-culture-based detection and serotyping of pneumococcal capsular polysaccharide.

Findlow H, Laher G, Balmer P, Broughton C, Carrol ED, Borrow R.

Clin Vaccine Immunol. 2009 Feb;16(2):222-9. doi: 10.1128/CVI.00292-08. Epub 2008 Dec 17.

30.

Immunogenicity of a reduced schedule of meningococcal group C conjugate vaccine given concomitantly with the Prevenar and Pediacel vaccines in healthy infants in the United Kingdom.

Southern J, Borrow R, Andrews N, Morris R, Waight P, Hudson M, Balmer P, Findlow H, Findlow J, Miller E.

Clin Vaccine Immunol. 2009 Feb;16(2):194-9. doi: 10.1128/CVI.00420-08. Epub 2008 Dec 17.

31.

CSF cytokine levels in preterm infants may reflect systemic inflammation and are independent of gestation.

Turner MA, Drury JA, Carlin A, O'Neill S, Pilling D, Barnes N, Balmer P, Newland P, Clark S, Kissack CM, Subhedar NV.

Early Hum Dev. 2009 Apr;85(4):259-62. doi: 10.1016/j.earlhumdev.2008.10.011. Epub 2008 Nov 20.

PMID:
19019580
32.

Serotype-specific immune unresponsiveness to pneumococcal conjugate vaccine following invasive pneumococcal disease.

Borrow R, Stanford E, Waight P, Helbert M, Balmer P, Warrington R, Slack M, George R, Miller E.

Infect Immun. 2008 Nov;76(11):5305-9. doi: 10.1128/IAI.00796-08. Epub 2008 Sep 8.

33.

Immune response to pneumococcal conjugate vaccination in asplenic individuals.

Stanford E, Print F, Falconer M, Lamden K, Ghebrehewet S, Phin N, Baxter D, Helbert M, McCann R, Andrews N, Balmer P, Borrow R, Kaczmarski E.

Hum Vaccin. 2009 Feb;5(2):85-91. Epub 2009 Feb 7.

PMID:
18758242
34.

A prospective study of etiology of childhood acute bacterial meningitis, Turkey.

Ceyhan M, Yildirim I, Balmer P, Borrow R, Dikici B, Turgut M, Kurt N, Aydogan A, Ecevit C, Anlar Y, Gulumser O, Tanir G, Salman N, Gurler N, Hatipoglu N, Hacimustafaoglu M, Celebi S, Coskun Y, Alhan E, Celik U, Camcioglu Y, Secmeer G, Gur D, Gray S.

Emerg Infect Dis. 2008 Jul;14(7):1089-96. doi: 10.3201/eid1407.070938.

35.

Comparison of phenotypically indistinguishable but geographically distinct Neisseria meningitidis Group B isolates in a serum bactericidal antibody assay.

Findlow J, Holland A, Andrews N, Weynants V, Sotolongo F, Balmer P, Poolman J, Borrow R.

Clin Vaccine Immunol. 2007 Nov;14(11):1451-7. Epub 2007 Sep 19.

36.
37.

Age-specific seroprevalence of serogroup C meningococcal serum bactericidal antibody activity and serogroup A, C, W135 and Y-specific IgG concentrations in the Turkish population during 2005.

Ceyhan M, Yildirim I, Balmer P, Riley C, Laher G, Andrews N, Borrow R, Kurt N, Turgut M, Aydogan A, Ecevit C, Uysal G, Schultze V.

Vaccine. 2007 Oct 10;25(41):7233-7. Epub 2007 Aug 1.

PMID:
17707957
38.

On the neisserial vaccine quest: Neisseria Vaccines 2007.

Pajón R, Niebla O, Yero D, Pérez O, Cabrera O, Findlow J, Balmer P, Borrow R.

Expert Rev Anti Infect Ther. 2007 Aug;5(4):545-50. No abstract available.

PMID:
17678419
39.

Neisseria vaccines 2007.

Findlow J, Balmer P, Yero D, Niebla O, Pajón R, Borrow R.

Expert Rev Vaccines. 2007 Aug;6(4):485-9. No abstract available.

PMID:
17669003
40.

Different trends of MRSA and VRE in a German hospital, 1999-2005.

Goll C, Balmer P, Schwab F, Rüden H, Eckmanns T.

Infection. 2007 Jun;35(4):245-9. Epub 2007 Jul 23.

PMID:
17646911
42.

Issues surrounding standardization of meningococcal group W135 serology.

Balmer P, Borrow R.

Vaccine. 2007 Sep 3;25 Suppl 1:A63-8. Epub 2007 May 7. Review.

PMID:
17544550
43.

Seroprevalence of bactericidal and anti-outer membrane vesicle antibodies to Neisseria meningitidis group B in England.

Trotter C, Findlow J, Balmer P, Holland A, Barchha R, Hamer N, Andrews N, Miller E, Borrow R.

Clin Vaccine Immunol. 2007 Jul;14(7):863-8. Epub 2007 May 9.

44.

High pneumococcal DNA loads are associated with mortality in Malawian children with invasive pneumococcal disease.

Carrol ED, Guiver M, Nkhoma S, Mankhambo LA, Marsh J, Balmer P, Banda DL, Jeffers G; IPD Study Group, White SA, Molyneux EM, Molyneux ME, Smyth RL, Hart CA.

Pediatr Infect Dis J. 2007 May;26(5):416-22.

45.
46.

Chemokine responses are increased in HIV-infected Malawian children with invasive pneumococcal disease.

Carrol ED, Mankhambo LA, Balmer P, Nkhoma S, Banda DL, Guiver M, Jeffers G, Makwana N, Molyneux EM, Molyneux ME, Smyth RL, Hart CA; Invasive Pneumococcal Disease Study Group.

J Acquir Immune Defic Syndr. 2007 Apr 1;44(4):443-50.

47.

Immunogenicity and induction of immunological memory of the heptavalent pneumococcal conjugate vaccine in preterm UK infants.

Ruggeberg JU, Collins C, Clarke P, Johnson N, Sinha R, Everest N, Chang J, Stanford E, Balmer P, Borrow R, Martin S, Robinson MJ, Moxon ER, Pollard AJ, Heath PT.

Vaccine. 2007 Jan 4;25(2):264-71. Epub 2006 Aug 4.

PMID:
17070968
49.

Anti-pneumococcal antibody titre measurement: what useful information does it yield?

Balmer P, Cant AJ, Borrow R.

J Clin Pathol. 2007 Apr;60(4):345-50. Epub 2006 Sep 1. Review.

50.

Early appearance of bactericidal antibodies after polysaccharide challenge of toddlers primed with a group C meningococcal conjugate vaccine: what is its role in the maintenance of protection?

Tsai TF, Borrow R, Gnehm HE, Vaudaux B, Heininger U, Desgrandchamps D, Aebi C, Balmer P, Pedersen RD, Fritzell B, Siegrist CA.

Clin Vaccine Immunol. 2006 Aug;13(8):854-61.

Supplemental Content

Loading ...
Support Center